{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:13:07Z","timestamp":1789078387875,"version":"build-2803163510"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>\n                    C-reactive protein (CRP) is an inflammatory biomarker with prognostic value in heart failure, but its role in HeartMate 3 (HM3) left ventricular assist device recipients is unclear. We retrospectively analyzed 188 adult HM3 recipients (2016\u20132025), stratified by preoperative CRP into low-CRP (\u226410\u2009mg\/L, n = 65) and high-CRP (&gt;10\u2009mg\/L, n = 123) groups. High-CRP patients presented with a sicker phenotype, with higher INTERMACS profile 1\/preoperative extracorporeal membrane oxygenation (ECMO) support (50%\n                    <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                    3%) and greater renal, hepatic, hematologic, and nutritional derangement. In-hospital and 30 day mortality were higher with high CRP (23%\n                    <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                    5%,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    = 0.001; 19% vs 3%,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    = 0.003); overall mortality did not differ (47%\n                    <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                    40%,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    = 0.360). In a parsimonious multivariable model adjusted for age, preoperative CRP (odds ratio [OR], 1.05 per 10\u2009mg\/L,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    = 0.006) and albumin (OR, 0.32 per g\/dl,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    = 0.003) independently predicted in-hospital mortality; a seven-variable model was unstable due to INTERMACS-ECMO collinearity. C-reactive protein discriminated in-hospital mortality (area under the curve [AUC] = 0.77); a 10\u2009mg\/L threshold was sensitive (90%) but not specific (40%). High CRP was also associated with a 4.5-fold increase in tracheostomy (36%\n                    <jats:italic toggle=\"yes\">vs.<\/jats:italic>\n                    8%,\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    &lt; 0.001) and prolonged ventilation. Preoperative CRP, interpreted with albumin, is a practical risk signal identifying a high-risk inflammatory\u2013nutritional phenotype with greater perioperative morbidity in HM3 recipients.\n                  <\/jats:p>","DOI":"10.1097\/mat.0000000000002846","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:00:47Z","timestamp":1789077647000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["C-Reactive Protein Predicts Outcomes in HeartMate 3 Left Ventricular Assist Device Recipients"],"prefix":"10.1097","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8111-4872","authenticated-orcid":false,"given":"Jonathan","family":"Eisenberger","sequence":"first","affiliation":[{"name":"From the Heart Transplantation Unit, Department of Cardiac Surgery, Leviev Heart Center, Chaim Sheba Medical Center, Tel-Hashomer, affiliated with the Gray Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal Ran","family":"Nachum","sequence":"additional","affiliation":[{"name":"From the Heart Transplantation Unit, Department of Cardiac Surgery, Leviev Heart Center, Chaim Sheba Medical Center, Tel-Hashomer, affiliated with the Gray Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shmuel","family":"Somer","sequence":"additional","affiliation":[{"name":"From the Heart Transplantation Unit, Department of Cardiac Surgery, Leviev Heart Center, Chaim Sheba Medical Center, Tel-Hashomer, affiliated with the Gray Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Malayev","sequence":"additional","affiliation":[{"name":"From the Heart Transplantation Unit, Department of Cardiac Surgery, Leviev Heart Center, Chaim Sheba Medical Center, Tel-Hashomer, affiliated with the Gray Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kogan","sequence":"additional","affiliation":[{"name":"From the Heart Transplantation Unit, Department of Cardiac Surgery, Leviev Heart Center, Chaim Sheba Medical Center, Tel-Hashomer, affiliated with the Gray Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonid","family":"Sternik","sequence":"additional","affiliation":[{"name":"From the Heart Transplantation Unit, Department of Cardiac Surgery, Leviev Heart Center, Chaim Sheba Medical Center, Tel-Hashomer, affiliated with the Gray Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Morgan","sequence":"additional","affiliation":[{"name":"From the Heart Transplantation Unit, Department of Cardiac Surgery, Leviev Heart Center, Chaim Sheba Medical Center, Tel-Hashomer, affiliated with the Gray Faculty of Medicine, Tel Aviv University, Ramat Gan, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"R1-20260910","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2022.01.017","article-title":"Trends and outcomes of left ventricular assist device therapy: JACC focus seminar.","volume":"79","author":"Varshney","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R2-20260910","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/j.jacc.2023.07.019","article-title":"Durable mechanical circulatory support: JACC scientific statement.","volume":"82","author":"Tedford","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R3-20260910","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.athoracsur.2022.01.031","article-title":"Advancing quality metrics for durable left ventricular assist device implant: Analysis of the Society of Thoracic Surgeons INTERMACS database.","volume":"113","author":"Pienta","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"R4-20260910","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.3389\/fimmu.2018.02651","article-title":"The inflammatory response to ventricular assist devices.","volume":"9","author":"Radley","year":"2018","journal-title":"Front Immunol"},{"key":"R5-20260910","first-page":"348","article-title":"Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devices.","volume":"31","author":"Grosman-Rimon","year":"2015","journal-title":"Can J Cardiol"},{"key":"R6-20260910","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jacc.2023.05.035","article-title":"C-reactive protein and risk of incident heart failure in patients with cardiovascular disease.","volume":"82","author":"Burger","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R7-20260910","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/MAT.0000000000001327","article-title":"C-reactive protein levels predict outcomes in continuous-flow left ventricular assist device patients: An INTERMACS analysis.","volume":"67","author":"Batra","year":"2021","journal-title":"ASAIO J"},{"key":"R8-20260910","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.jacc.2011.06.017","article-title":"Predictors of in-hospital mortality in children after long-term ventricular assist device insertion.","volume":"58","author":"Fan","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R9-20260910","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MAT.0000000000000674","article-title":"Different clinical course and complications in Interagency Registry for Mechanically Assisted Circulatory Support 1 (INTERMACS) patients managed with or without extracorporeal membrane oxygenation.","volume":"64","author":"Han","year":"2018","journal-title":"ASAIO J"},{"key":"R10-20260910","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/aor.13897","article-title":"Outcomes of left ventricular assist device implantation for advanced heart failure in critically ill patients (INTERMACS 1 and 2): A retrospective study.","volume":"45","author":"Zhigalov","year":"2021","journal-title":"Artif Organs"},{"key":"R11-20260910","doi-asserted-by":"crossref","first-page":"e90802","DOI":"10.1371\/journal.pone.0090802","article-title":"Relationship between pre-implant interleukin-6 levels, inflammatory response, and early outcome in patients supported by left ventricular assist device: A prospective study.","volume":"9","author":"Caruso","year":"2014","journal-title":"PLoS One"},{"key":"R12-20260910","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cardfail.2022.11.003","article-title":"The International Society for Heart and Lung Transplantation\/Heart Failure Society of America guideline on acute mechanical circulatory support.","volume":"29","author":"Bernhardt","year":"2023","journal-title":"J Card Fail"},{"key":"R13-20260910","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jamacardio.2024.4849","article-title":"Aspirin and hemocompatibility after LVAD implantation in patients with atherosclerotic vascular disease: A secondary analysis from the ARIES-HM3 randomized clinical trial.","volume":"10","author":"Gustafsson","year":"2025","journal-title":"JAMA Cardiol"},{"issue":"8 pt 1","key":"R14-20260910","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.jchf.2023.04.014","article-title":"Late right heart failure after left ventricular assist device implantation: Contemporary insights and future perspectives.","volume":"11","author":"Rajapreyar","year":"2023","journal-title":"JACC Heart Fail"},{"key":"R15-20260910","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00134-020-05939-1","article-title":"Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS).","volume":"46","author":"Akin","year":"2020","journal-title":"Intensive Care Med"},{"key":"R16-20260910","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/icvts\/ivy102","article-title":"Statistical primer: How to deal with missing data in scientific research?","volume":"27","author":"Papageorgiou","year":"2018","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"R17-20260910","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jacc.2021.06.035","article-title":"Contemporary left ventricular assist device outcomes in an aging population: An STS INTERMACS analysis.","volume":"78","author":"Emerson","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"R18-20260910","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.jchf.2016.07.014","article-title":"The HeartMate Risk Score identifies patients with similar mortality risk across all INTERMACS profiles in a large multicenter analysis.","volume":"4","author":"Adamo","year":"2016","journal-title":"JACC Heart Fail"},{"key":"R19-20260910","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.jacc.2017.04.031","article-title":"Left ventricular assist devices for lifelong support.","volume":"69","author":"Pinney","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R20-20260910","doi-asserted-by":"crossref","first-page":"e006369","DOI":"10.1161\/CIRCHEARTFAILURE.119.006369","article-title":"Clinical implications of respiratory failure in patients receiving durable left ventricular assist devices for end-stage heart failure.","volume":"12","author":"Miller","year":"2019","journal-title":"Circ Heart Fail"},{"key":"R21-20260910","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/jocs.13745","article-title":"Predictive value of preoperative serum albumin levels on outcomes in patients undergoing LVAD implantation.","volume":"33","author":"Critsinelis","year":"2018","journal-title":"J Card Surg"},{"key":"R22-20260910","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jacc.2023.05.066","article-title":"Predictors of 5-year mortality in patients managed with a magnetically levitated left ventricular assist device.","volume":"82","author":"Nayak","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"R23-20260910","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.athoracsur.2024.11.039","article-title":"The Society of Thoracic Surgeons National INTERMACS database risk model for durable left ventricular assist device implantation.","volume":"119","author":"Pagani","year":"2025","journal-title":"Ann Thorac Surg"},{"key":"R24-20260910","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1053\/j.jvca.2019.01.043","article-title":"Prevalence and clinical impact of systemic inflammatory reaction after cardiac surgery.","volume":"33","author":"Squiccimarro","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R25-20260910","first-page":"1686","article-title":"Associations of inflammatory biomarkers with the risk of morbidity and mortality after cardiac surgery: A systematic review and meta-analysis.","volume":"39","author":"Heo","year":"2023","journal-title":"Can J Cardiol"},{"key":"R26-20260910","doi-asserted-by":"crossref","first-page":"10891","DOI":"10.3390\/ijms252010891","article-title":"The crucial triad: Endothelial glycocalyx, oxidative stress, and inflammation in cardiac surgery\u2014exploring the molecular connections.","volume":"25","author":"\u0106urko-Cofek","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R27-20260910","doi-asserted-by":"crossref","first-page":"156987","DOI":"10.1016\/j.cyto.2025.156987","article-title":"Inflammatory biomarkers to predict clinical outcomes in adults after cardiac surgery in China: A prospective observational trial.","volume":"193","author":"Liu","year":"1569","journal-title":"Cytokine"},{"key":"R28-20260910","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamasurg.2019.1153","article-title":"Guidelines for perioperative care in cardiac surgery: Enhanced Recovery After Surgery Society recommendations.","volume":"154","author":"Engelman","year":"2019","journal-title":"JAMA Surg"},{"key":"R29-20260910","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00595-022-02566-9","article-title":"Preoperative hypoalbuminemia in patients undergoing cardiac surgery: A meta-analysis.","volume":"53","author":"Xu","year":"2023","journal-title":"Surg Today"},{"key":"R30-20260910","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.athoracsur.2023.12.006","article-title":"Perioperative care in cardiac surgery: A joint consensus statement by the Enhanced Recovery After Surgery (ERAS) Cardiac Society, ERAS International Society, and the Society of Thoracic Surgeons (STS).","volume":"117","author":"Grant","year":"2024","journal-title":"Ann Thorac Surg"},{"key":"R31-20260910","first-page":"72","article-title":"Preoperative optimization of the heart failure patient undergoing cardiac surgery.","volume":"33","author":"Pichette","year":"2017","journal-title":"Can J Cardiol"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MAT.0000000000002846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:00:50Z","timestamp":1789077650000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MAT.0000000000002846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":31,"URL":"https:\/\/doi.org\/10.1097\/mat.0000000000002846","relation":{},"ISSN":["1058-2916","1538-943X"],"issn-type":[{"value":"1058-2916","type":"print"},{"value":"1538-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}